This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Tracy Hampton, PhD

JAMA. 2006;296:756.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In an attempt to accelerate the pace of HIV vaccine development, the Bill & Melinda Gates Foundation has awarded 16 grants totaling $287 million over 5 years to create an international network of collaborative research consortia. These consortia will bring together more than 165 investigators from 19 countries to tackle various challenges in HIV vaccine discovery and development.

"With 11 000 new HIV infections occurring every day, a preventive vaccine is our best long-term hope for controlling the AIDS epidemic" said Nicholas Hellmann, MD, acting director of the Gates Foundation's HIV, TB, and Reproductive Health Program.

Specifically, 11 grants will support efforts to create an effective HIV vaccine and 5 grants will establish central facilities to support comparative studies of vaccine candidates created by the consortia. As a condition for receiving funding, the consortia must agree to use the central facilities to test vaccine candidates, share information with . . . [Full Text of this Article]

VARIED RESEARCH



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?